Examination of sodium-glucose cotransporter-2 inhibitors in kidney transplant recipients in the real world.

Published Date: 08 Nov 2023

Although little is known about their safety, sodium-glucose cotransporter-2 (SGLT2) inhibitors lower blood sugar levels and have additional positive effects on kidney and heart health in both diabetics and non-diabetics.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Stem Cell Selection Unneeded for SSc Transplant Therapy?

2.

Lung Transplant for Lung Cancer: Promising, in Rare Cases

3.

Rural-urban disparities seen in cervical cancer

4.

Obesity linked to subsequent neoplasms in childhood cancer survivors

5.

New policy review highlights the importance of health-related quality of life in advanced cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot